Literature DB >> 22618210

Impact of a best clinical therapy management on surgery for ulcerative colitis.

R F Leal, M de Lourdes Setsuko Ayrizono, P de Sene Portel Oliveira, J J Fagundes, C S R Coy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22618210     DOI： 10.1007/s10151-012-0842-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  4 in total

1.  Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

Authors:  A Gustavsson; G Järnerot; E Hertervig; I Friis-Liby; L Blomquist; P Karlén; C Grännö; M Vilien; M Ström; H Verbaan; P M Hellström; A Magnuson; J Halfvarson; C Tysk
Journal:  Aliment Pharmacol Ther       Date:  2010-08-18       Impact factor: 8.171

2.  Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis.

Authors:  Z Yang; Q Wu; K Wu; D Fan
Journal:  Aliment Pharmacol Ther       Date:  2009-11-19       Impact factor: 8.171

3.  Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.

Authors:  William J Sandborn; Paul Rutgeerts; Brian G Feagan; Walter Reinisch; Allan Olson; Jewel Johanns; Jiandong Lu; Kevin Horgan; Daniel Rachmilewitz; Stephen B Hanauer; Gary R Lichtenstein; Willem J S de Villiers; Daniel Present; Bruce E Sands; Jean Frédéric Colombel
Journal:  Gastroenterology       Date:  2009-07-28       Impact factor: 22.682

Review 4.  Pouchitis: lessons for inflammatory bowel disease.

Authors:  Hao Wu; Bo Shen
Journal:  Curr Opin Gastroenterol       Date:  2009-07       Impact factor: 3.287
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.